1. Home
  2. SCM vs MRVI Comparison

SCM vs MRVI Comparison

Compare SCM & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCM
  • MRVI
  • Stock Information
  • Founded
  • SCM 2012
  • MRVI 2014
  • Country
  • SCM United States
  • MRVI United States
  • Employees
  • SCM N/A
  • MRVI N/A
  • Industry
  • SCM Finance/Investors Services
  • MRVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • SCM Finance
  • MRVI Health Care
  • Exchange
  • SCM Nasdaq
  • MRVI Nasdaq
  • Market Cap
  • SCM 397.8M
  • MRVI 376.2M
  • IPO Year
  • SCM 2012
  • MRVI 2020
  • Fundamental
  • Price
  • SCM $12.24
  • MRVI $3.24
  • Analyst Decision
  • SCM Hold
  • MRVI Hold
  • Analyst Count
  • SCM 1
  • MRVI 9
  • Target Price
  • SCM $13.00
  • MRVI $4.54
  • AVG Volume (30 Days)
  • SCM 232.2K
  • MRVI 1.7M
  • Earning Date
  • SCM 11-06-2025
  • MRVI 11-06-2025
  • Dividend Yield
  • SCM 13.07%
  • MRVI N/A
  • EPS Growth
  • SCM 11.71
  • MRVI N/A
  • EPS
  • SCM 1.43
  • MRVI N/A
  • Revenue
  • SCM $102,761,445.00
  • MRVI $219,830,000.00
  • Revenue This Year
  • SCM N/A
  • MRVI N/A
  • Revenue Next Year
  • SCM $1.23
  • MRVI $7.27
  • P/E Ratio
  • SCM $8.53
  • MRVI N/A
  • Revenue Growth
  • SCM N/A
  • MRVI N/A
  • 52 Week Low
  • SCM $11.19
  • MRVI $1.67
  • 52 Week High
  • SCM $15.56
  • MRVI $8.29
  • Technical
  • Relative Strength Index (RSI)
  • SCM 38.63
  • MRVI 50.18
  • Support Level
  • SCM $12.01
  • MRVI $3.32
  • Resistance Level
  • SCM $12.37
  • MRVI $3.55
  • Average True Range (ATR)
  • SCM 0.29
  • MRVI 0.19
  • MACD
  • SCM 0.08
  • MRVI -0.04
  • Stochastic Oscillator
  • SCM 54.32
  • MRVI 8.82

About SCM Stellus Capital Investment Corporation

Stellus Capital Investment Corp is a closed-end, non-diversified management investment company. Its objective is to maximize the total return to its stockholders in the form of current income and capital appreciation. It invests in private middle-market companies through a first lien, second lien, and unsecured debt financing, often with a corresponding equity investment. The company invests in various sectors, such as business services, energy, general industrial, government services, healthcare, software, and specialty finance. The business activity of the firm is functioned through the United States and it generates revenue in the form of interest income on debt investments and capital gains and distributions.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: